Atrial Arrhythmias: Advances in Diagnostic Implications, Clinical Management and Precision Medicine
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 8281
Special Issue Editors
Interests: atrial fibrillation; arrhythmias; clinical electrophysiology; interventional electrophysiology; catheter ablation; cardiac pacing; anticoagulant therapy; antiarrhythmic drugs; cardiomyopathies; sports cardiology
Interests: arrhythmias; atrial fibrillation; pacemakers; cardiac electrophysiology; catheter ablation; clinical electrophysiology; interventional electrophysiology
Special Issue Information
Dear Colleagues,
The global burden of atrial arrhythmias is growing, mostly driven by the increased detection of atrial fibrillation (AF). New tools for atrial arrhythmia diagnosis, together with the remote monitoring of cardiac implantable electronic devices, shorten the delay from arrhythmia onset to diagnosis. However, the diagnostic implications of subclinical atrial arrhythmias are still a matter of debate, and their treatment varies greatly based on their duration. Furthermore, even the management of clinically overt atrial tachyarrhythmias might depend on the burden of the arrhythmia. The treatment of these common arrhythmias either aims to improve symptoms or to reduce the associated risk of thromboembolic events. Cather ablation is superior to antiarrhythmic drugs to eliminate or reduce AF recurrences, but timely diagnosis and intervention are fundamental. Despite the constant research, there are still some safety concerns in the use of oral anticoagulants, which must be offered to select patients based on their thrombotic and hemorrhagic risks. To ameliorate the safety profile of direct oral anticoagulants, recent studies have focused on populations which are under-represented in clinical trials and pharmacological interactions. Moreover, newer anticoagulants are under investigation. Alternative interventional solutions exist for those with contraindication for anticoagulation (i.e., left atrial appendage occlusion). Finally, precision approaches to atrial arrhythmias are emerging. In the near future, genetic testing may help to predict AF onset and recurrence, and could influence the choice of strategy (rhythm vs. rate control) and antiarrhythmic or anticoagulant therapy.
The aim of this Special Issue is to gather up-to-date scientific evidence on the management of atrial arrhythmias, with particular reference to diagnostic implications, clinical management and precision medicine. We are pleased to invite you and your co-workers to submit your original research articles and review articles on this topic.
Dr. Riccardo Vio
Prof. Dr. Riccardo Proietti
Dr. Paolo China
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- atrial arrhythmia
- anticoagulation
- stroke
- antiarrhythmic drug
- catheter ablation
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.